Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis
E. Rosato, C. Letizia, M. Proietti, A. Aversa, G. Menghi, C. Rossi, E. Torella, D. Cotesta, L. Petramala, R. Bruzziches, G. Spera, S. Pisarri, F. Salsano
Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |